Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA
· Real-Time Price · USD
1.25
0.07 (5.93%)
At close: Sep 16, 2025, 3:59 PM
1.25
0.00%
After-hours: Sep 16, 2025, 04:10 PM EDT
Ernexa Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 4.32M | 1.92M | 1.73M | 4.26M | 2.59M | 5.12M | 7.58M | 4.55M | 1.84M | 5.4M | 11.45M | 13.25M | 19.41M | 23.5M | 16.98M | 24.38M | 50.16M | 8.41M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | 4.09M | 4.09M | 4.09M | 4.09M | 4.09M | 8K | 59K | 68K | 89K | 385K | 1M | 1M | n/a | n/a |
Other Long-Term Assets | 117K | 118K | 118K | 120K | 120K | 120K | 120K | 8.14M | 5.47M | 5.34M | 5.23M | 819K | 477K | 421K | 522K | 519.47K | 514.88K | 488.53K |
Receivables | 154K | 156K | 437K | 187K | 228K | 351K | 425K | 1.78M | 984K | 647K | 951K | 926K | 694K | 835K | 684K | 23.3K | 23.3K | 53.41K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -951K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 323K | 137K | 186K | 279K | 769K | 697K | 1.6M | 704K | 1.07M | 471K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 4.79M | 2.21M | 2.35M | 4.73M | 3.58M | 6.16M | 9.6M | 7.03M | 3.89M | 6.51M | 13.68M | 15.85M | 21.93M | 25.14M | 18.77M | 25.76M | 51.94M | 8.71M |
Property-Plant & Equipment | 631K | 686K | 755K | 824K | 36.64M | 37.23M | 33.27M | 35.03M | 35.55M | 1.2M | 1.27M | 2.14M | 2.37M | 1.4M | 3.24M | 3.21M | 3.35M | 2.59M |
Goodwill & Intangibles | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 2.04M | 8.03M | 8.9M | 8.9M | 8.9M | 8.9M |
Total Long-Term Assets | 2.79M | 2.85M | 2.92M | 2.99M | 42.9M | 43.49M | 39.53M | 45.22M | 43.06M | 8.59M | 8.6M | 5.07M | 4.98M | 10.24M | 13.66M | 13.64M | 12.77M | 11.98M |
Total Assets | 7.58M | 5.06M | 5.27M | 7.72M | 46.49M | 49.66M | 49.13M | 52.25M | 46.95M | 15.11M | 22.28M | 20.93M | 26.9M | 35.38M | 32.43M | 39.39M | 64.71M | 20.7M |
Account Payables | 1.32M | 1.27M | 1.72M | 2.19M | 2.19M | 2.06M | 1.07M | 1.46M | 2.67M | 1.46M | 1.62M | 1.15M | 1.48M | 1.11M | 1.75M | 996.26K | 3.68M | 1.81M |
Deferred Revenue | n/a | n/a | n/a | n/a | 189K | 189K | 190K | 349K | 250K | 250K | n/a | n/a | n/a | n/a | n/a | 2.13M | 1.92M | n/a |
Short-Term Debt | 217K | 2.25M | 207K | 776K | 4.27M | 2.87M | 2.22M | 1.64M | 173K | 168K | 1.75M | 439K | 390K | 149K | n/a | 410K | 719.9K | 642.24K |
Other Current Liabilities | 887K | 5.35M | -195K | 6.66M | -1.79M | -439K | 773K | 4.9M | 3.81M | 3.4M | 2.92M | 3.91M | 3.25M | 533K | 840K | 2.16M | 2.52M | 572.08K |
Total Current Liabilities | 2.65M | 10.44M | 2.94M | 9.95M | 9.6M | 7.77M | 6.57M | 9.63M | 7.17M | 5.41M | 7.65M | 7.47M | 7.12M | 3.68M | 3.68M | 4.56M | 7.68M | 3.9M |
Long-Term Debt | 376K | 419K | 477K | 32.04M | 8.89M | 8.01M | 6.77M | 3.45M | 331K | 1.61M | 2.09M | n/a | n/a | n/a | n/a | n/a | n/a | 77.67K |
Other Long-Term Liabilities | 113K | 152K | 153K | 10.59M | 175K | 377K | 307K | 360K | 194K | -378K | -462K | 2.32M | 2.57M | 13.36M | 19.95M | 19.38M | 19.31M | 19.31M |
Total Long-Term Liabilities | 489K | 571K | 630K | 43.16M | 45.41M | 45.3M | 40.33M | 39.06M | 35.92M | 2.32M | 2.52M | 4.65M | 5M | 14.38M | 22.25M | 21.79M | 21.84M | 21.22M |
Total Liabilities | 3.14M | 11.01M | 3.57M | 53.11M | 55.01M | 53.07M | 46.9M | 48.69M | 43.09M | 7.73M | 10.17M | 12.11M | 12.12M | 18.07M | 25.93M | 26.35M | 29.53M | 25.12M |
Total Debt | 593K | 2.88M | 684K | 33.55M | 49.2M | 47.45M | 41.84M | 41.24M | 37.22M | 3.53M | 4.14M | 2.76M | 2.82M | 1.17M | 2.72M | 3.23M | 3.63M | 2.83M |
Book Value | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Book Value Per Share | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock | 37K | 262K | 257K | 27K | 27K | 27K | 27K | 27K | 27K | 26K | 26K | 15K | 287K | 287K | 260K | 260.22K | 223.54K | 207.53K |
Retained Earnings | -242.88M | -239.74M | -231.54M | -225.77M | -199.16M | -193.63M | -186.98M | -180.82M | -175.23M | -170.71M | -165.3M | -160.8M | -153.48M | -150.08M | -159.7M | -151.23M | -65.18M | -55.08M |
Comprehensive Income | n/a | n/a | n/a | n/a | -1K | -1K | n/a | -1K | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 4.44M | -5.95M | 1.7M | -45.39M | -8.53M | -3.41M | 2.23M | 3.56M | 3.87M | 7.38M | 12.11M | 8.81M | 14.78M | 17.31M | 6.5M | 13.04M | 35.18M | -4.42M |
Total Investments | n/a | n/a | n/a | n/a | 4.09M | 4.09M | 4.09M | 4.09M | 4.09M | 8K | 59K | 68K | 89K | 385K | 1M | 1M | n/a | n/a |